| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |